dc.contributor.author | Aslan, Ahmet | |
dc.date.accessioned | 2022-09-30T12:44:18Z | |
dc.date.available | 2022-09-30T12:44:18Z | |
dc.date.issued | 2021 | en_US |
dc.identifier.uri | https://dergipark.org.tr/tr/pub/medalanya/issue/69087/1076252 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12868/1741 | |
dc.description.abstract | Osteoporosis (OP); It is a metabolic bone disease characterized by decreased bone mineral density (BMD) and bone strength, increased bone fragility and fracture risk, and deterioration in the microarchitecture of bone tissue. The most important cause of morbidity and mortality in OP are fragility fractures such as osteoporotic hip fractures. Prevention and treatment of osteoporosis can prevent hip fractures and comorbidities. In this paper, the available information about Osteoporosis and Osteoporotic fractures is briefly reviewed. | en_US |
dc.language.iso | eng | en_US |
dc.relation.isversionof | https://doi.org/10.30565/medalanya.1076252 | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Osteoporosis | en_US |
dc.subject | Bone mineral density | en_US |
dc.subject | Osteoporotic fractures | en_US |
dc.subject | Bisphosphonates | en_US |
dc.subject | Treatment | en_US |
dc.title | Osteoporosis and Fragilty Fractures: An Overview. | en_US |
dc.type | editorial | en_US |
dc.contributor.department | ALKÜ, Fakülteler, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü | en_US |
dc.identifier.volume | 6 | en_US |
dc.identifier.issue | 1 | en_US |
dc.identifier.startpage | 1 | en_US |
dc.identifier.endpage | 1 | en_US |
dc.relation.journal | Acta Medica Alanya | en_US |
dc.relation.publicationcategory | Makale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanı | en_US |